Understood reports that the FDA has approved Simtriyo, a new ADHD medication targeting dopamine, norepinephrine, and serotonin, promising fewer side effects.

The post-exercise "warm glow" increases generosity towards good causes, according to the research.

LMNT reports that caffeine blocks fatigue signals without creating energy, enhancing focus by stimulating neurotransmitters.